Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sample Proportion and Population Proportion01:20

Sample Proportion and Population Proportion

5.3K
Collecting samples or responses from an entire population takes significant time and effort, so a researcher collects responses from only a sample of that population. Suppose a study needs to collect information about a specific mobile application. After sample collection, the researcher analyzes the data and discovers that most individuals in the sample use that specific mobile application. The sample proportion measures the number of individuals in a sample who either use or don't use the...
5.3K
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

4.1K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
4.1K
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

3.3K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.3K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133
What are Estimates?01:06

What are Estimates?

5.0K
It isn't easy to measure a parameter such as the mean height or the mean weight of a population. So, we draw samples from the population and calculate the mean height or mean weight of the individuals in the sample. This sample data acts as a representative measure of the population parameter. These sample statistics are known as estimates. 
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
5.0K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mosunetuzumab Successfully Treated Rituximab-Refractory Lymphoma-Associated Protein-Losing Enteropathy With Concomitant Immune Thrombocytopenia in Follicular Lymphoma: A Case Report.

EJHaem·2026
Same author

Burden of invasive group a streptococcus infection in Australia: a systematic review and meta-analysis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same author

Transboundary Animal Diseases Associated With Cross-Border Camel Movement. A Systematic Review and Meta-Analysis.

Transboundary and emerging diseases·2026
Same author

Synergistic effects of elranatamab and Juzentaihoto, Japanese traditional herbal medicine, in triple-class-exposed relapsed/refractory multiple myeloma with extramedullary disease: a case report.

International journal of hematology·2026
Same author

Stroke survivors' preferences for recovery-promoting drugs: development and piloting of a discrete choice experiment.

Pilot and feasibility studies·2026
Same author

Too Hot, Too Wet: Bayesian Spatial Modeling of Climate-Driven Salmonella Risk in New South Wales, Australia, 1991-2022.

GeoHealth·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.5K

HIV estimation using population-based surveys with non-response: A partial identification approach.

Oyelola A Adegboye1, Tomoki Fujii2, Denis Heng-Yan Leung2

  • 1Menzies School of Health Research, Charles Darwin University, Casuarina, Australia.

Statistics in Medicine
|May 17, 2024
PubMed
Summary
This summary is machine-generated.

Estimating HIV prevalence from survey data is challenging due to non-response. This study introduces a robust partial identification method using instrumental variables, offering more informative and credible HIV estimates without strict assumptions.

Keywords:
HIVdemographic and health surveysinstrumental variablenon‐responsepartial identification

More Related Videos

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.1K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.6K

Related Experiment Videos

Last Updated: Jun 26, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.5K
Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.1K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.6K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Public Health

Background:

  • Estimating HIV prevalence using Demographic and Health Surveys (DHS) data is complicated by non-response and test refusals.
  • Standard adjustment methods like imputation assume data are missing at random, which is often not the case.
  • Instrumental variable methods can account for non-random missingness but rely heavily on instrument validity.

Purpose of the Study:

  • To develop and evaluate a robust method for HIV prevalence estimation that addresses non-response and test refusals in survey data.
  • To improve the informativeness and credibility of HIV prevalence estimates derived from population-based surveys.
  • To compare the performance of the proposed method against conventional imputation and worst-case bounds.

Main Methods:

  • Utilized Manski's partial identification approach to construct instrumental variable bounds for HIV prevalence.
  • Employed a pool of candidate instruments, not requiring all to be valid.
  • Evaluated the method through a simulation study and applied it to DHS data from Zambia, Malawi, and Kenya.

Main Results:

  • Imputation methods produced significantly biased HIV prevalence estimates under mild non-random missingness.
  • Worst-case identification bounds were robust but lacked informativeness.
  • The proposed union of instrumental variable bounds balanced informativeness and robustness, even with some invalid instruments.

Conclusions:

  • Partial identification bounds offer a credible and robust approach to HIV prevalence estimation without stringent assumptions about non-response mechanisms.
  • The union of instrumental variable bounds provides a more informative alternative to worst-case bounds while maintaining robustness.
  • This method is crucial for accurate HIV surveillance using population-based survey data affected by non-response.